United States Biotechnology & Medical Research

Adaptive Biotechnologies Corp (ADPT)

Track

Track

Adaptive Biotechnologies Corp experienced significant insider selling over the past ninety days, totaling approximately 128.5 million dollars. These transactions occurred following a positive earnings report and a 59.3 percent stock price increase. Key executives, including the CEO and former officers, divested substantial holdings as the equity reached near-annual highs.
Ticker: ADPT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Adaptive Biotechnologies Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
309.24
Quantity 3,424 +27.2%
Value US$4,436,608
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
184.81
Quantity 90,723 +0.2%
Value US$1,082,984
2.6
FRANCIS LO Officer Officer
Transaction date
Proposed sale
Price
34.45
Quantity 17,615
Value US$1,419,131
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
27.00
Quantity 1,000 -0.3%
Value US$100,000
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
24.78
Quantity 1,000
Value US$100,000
OWEN KATEY EINTERZ Non-Executive Director
Transaction date
Sale
Price
26.00
Quantity 9,615 -10.9%
Value US$249,990
KATHERINE E OWEN Director Non-Executive Director
Transaction date
Proposed sale
Price
26.00
Quantity 9,615
Value US$249,990
2.1
Harlan Robins Former Officer Officer
Transaction date
Proposed sale
Price
25.44
Quantity 402,160
Value US$10,230,950
2.1
Harlan Robins Former Officer Officer
Transaction date
Proposed sale
Price
25.49
Quantity 215,632
Value US$5,496,460
2.3
HERSHBERG ROBERT Non-Executive Director
Transaction date
Sale
Price
24.41
Quantity 15,664 -25.1%
Value US$382,358
2.3
HERSHBERG ROBERT Non-Executive Director
Transaction date
Sale
Price
24.39
Quantity 15,000 -19.4%
Value US$365,850
1.9
ROBINS CHAD M CEO and Chairman Executive Director
Transaction date
Sale
Price
25.14
Quantity 204 -0.0%
Value US$5,129
1.9
ROBINS CHAD M CEO and Chairman Executive Director
Transaction date
Sale
Price
24.48
Quantity 278,472 -11.3%
Value US$6,816,995
2.3
ROBERT M HERSHBERG Director Non-Executive Director
Transaction date
Proposed sale
Price
24.40
Quantity 30,664
Value US$748,303
2.1
Harlan Robins Former Officer Officer
Transaction date
Proposed sale
Price
24.56
Quantity 261,044
Value US$6,411,241
1.9
Chad Robins Officer Officer
Transaction date
Proposed sale
Price
24.56
Quantity 278,676
Value US$6,844,283
1.9
ROBINS CHAD M CEO and Chairman Executive Director
Transaction date
Sale
Price
25.57
Quantity 2,525 -0.1%
Value US$64,564
1.9
ROBINS CHAD M CEO and Chairman Executive Director
Transaction date
Sale
Price
25.08
Quantity 318,799 -12.7%
Value US$7,995,479
3.4
NEUPERT PETER M Non-Executive Director
Transaction date
Sale
Price
25.16
Quantity 69,690 -34.8%
Value US$1,753,400
3.4
NEUPERT PETER M Non-Executive Director
Transaction date
Sale
Price
25.10
Quantity 40,000 -16.6%
Value US$1,004,000
3.4
NEUPERT PETER M Non-Executive Director
Transaction date
Sale
Price
25.23
Quantity 15,000 -5.9%
Value US$378,450
2.1
Harlan Robins Former Officer Officer
Transaction date
Proposed sale
Price
24.77
Quantity 300,992
Value US$7,455,572
1.9
Chad Robins Officer Officer
Transaction date
Proposed sale
Price
24.77
Quantity 321,324
Value US$7,959,195
3.4
PETER NEUPERT Director Non-Executive Director
Transaction date
Proposed sale
Price
25.15
Quantity 124,690
Value US$3,136,046
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -0.8%
Value US$75,000
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
24.93
Quantity 3,000
Value US$74,790
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
24.00
Quantity 1,299 -0.3%
Value US$31,176
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
22.56
Quantity 1,299
Value US$29,305
2.1
ROBINS HARLAN S Chief Scientific Officer Officer
Transaction date
Planned sale
Price
22.12
Quantity 213,702 -20.8%
Value US$4,727,088
2.1
ROBINS HARLAN S Chief Scientific Officer Officer
Transaction date
Planned sale
Price
21.72
Quantity 278,698 -21.4%
Value US$6,053,321
2.1
Harlan Robins Officer Officer
Transaction date
Proposed sale
Price
22.58
Quantity 492,400
Value US$11,118,392
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
23.00
Quantity 5,000 -1.2%
Value US$115,000
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
22.90
Quantity 5,000
Value US$114,500
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
22.59
Quantity 105,762 -31.4%
Value US$2,389,164
2.1
ROBINS HARLAN S Chief Scientific Officer Officer
Transaction date
Planned sale
Price
22.45
Quantity 146,889 -12.6%
Value US$3,297,658
2.1
ROBINS HARLAN S Chief Scientific Officer Officer
Transaction date
Planned sale
Price
21.74
Quantity 239,351 -17.0%
Value US$5,203,491
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
22.59
Quantity 44,838 -16.3%
Value US$1,012,890
2.1
Harlan Robins Officer Officer
Transaction date
Proposed sale
Price
21.19
Quantity 386,240
Value US$8,184,426
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
22.50
Quantity 42,261 -15.1%
Value US$950,872
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
22.18
Quantity 8,743 -3.0%
Value US$193,920
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
22.00
Quantity 487 -0.1%
Value US$10,714
2.6
FRANCIS LO Officer Officer
Transaction date
Proposed sale
Price
21.45
Quantity 199,260
Value US$4,274,127
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
21.45
Quantity 487
Value US$10,446
2.4
BENZENO SHARON Chief Commercial Ofc Imm Med Officer
Transaction date
Planned sale
Price
21.14
Quantity 154,768 -41.2%
Value US$3,271,796
2.4
SHARON BENZENO Officer Officer
Transaction date
Proposed sale
Price
20.96
Quantity 152,931
Value US$3,205,434
2.4
BENZENO SHARON Chief Commercial Ofc Imm Med Officer
Transaction date
Planned sale
Price
21.00
Quantity 11,034 -3.9%
Value US$231,714
2.4
SHARON BENZENO Officer Officer
Transaction date
Proposed sale
Price
20.25
Quantity 12,871
Value US$260,638
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
20.50
Quantity 5,000 -1.2%
Value US$102,500
1.4
GRIFFIN MICHELLE RENEE Non-Executive Director
Transaction date
Planned sale
Price
20.18
Quantity 52,084 -76.9%
Value US$1,051,055
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
19.34
Quantity 5,000
Value US$96,700
1.4
MICHELLE GRIFFIN Director Non-Executive Director
Transaction date
Proposed sale
Price
19.34
Quantity 52,084
Value US$1,007,305
2.1
ROBINS HARLAN S Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.01
Quantity 6,160 -0.4%
Value US$110,942
2.1
Harlan Robins Officer Officer
Transaction date
Proposed sale
Price
17.22
Quantity 6,160
Value US$106,075
2.1
ROBINS HARLAN S Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.37
Quantity 100,000 -6.6%
Value US$1,737,000
2.1
Harlan Robins Officer Officer
Transaction date
Proposed sale
Price
17.46
Quantity 100,000
Value US$1,746,000
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
19.00
Quantity 5,000 -1.2%
Value US$95,000
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
17.07
Quantity 5,000
Value US$85,350
2.1
BOBULSKY SUSAN Chief Commercial Officer, MRD Officer
Transaction date
Planned sale
Price
18.00
Quantity 11,000 -2.6%
Value US$198,000
2.6
LO FRANCIS Chief People Officer Officer
Transaction date
Planned sale
Price
17.49
Quantity 39,741 -13.7%
Value US$695,070
2.1
SUSAN BOBULSKY Officer Officer
Transaction date
Proposed sale
Price
15.99
Quantity 11,000
Value US$175,890
2.6
FRANCIS LO Officer Officer
Transaction date
Proposed sale
Price
15.99
Quantity 42,085
Value US$672,939
2.8
PISKEL KYLE Chief Financial Officer Officer
Transaction date
Sale
Price
13.04
Quantity 3,115 -1.2%
Value US$40,620
2.8
PISKEL KYLE Officer Officer
Transaction date
Proposed sale
Price
12.83
Quantity 3,160
Value US$40,543
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.23
Quantity 19,037 -4.8%
Value US$270,897
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.02
Quantity 19,060 -4.8%
Value US$267,221
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
13.74
Quantity 19,060 -4.7%
Value US$261,884
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.13
Quantity 19,060 -4.7%
Value US$269,318
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.66
Quantity 30,941 -7.3%
Value US$453,595
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.55
Quantity 19,060 -4.6%
Value US$277,323
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.57
Quantity 19,060 -4.5%
Value US$277,704
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.18
Quantity 19,060 -4.5%
Value US$270,271
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.61
Quantity 19,060 -4.4%
Value US$278,467
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.56
Quantity 19,060 -4.4%
Value US$277,514
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
14.08
Quantity 3,338 -0.8%
Value US$46,999
2.6
RUBINSTEIN JULIE President and COO Officer
Transaction date
Planned sale
Price
12.95
Quantity 15,722 -3.6%
Value US$203,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-16 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
3,424 +27.2%
309.24
US$4,436,608 		3,424 +27.2% 309.24 US$4,436,608
2026-09-18 2026-09-16 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
90,723 +0.2%
184.81
US$1,082,984 		90,723 +0.2% 184.81 US$1,082,984
2026-09-16 2026-09-16 PrS Proposed sale
2.6
FRANCIS LO

Officer

Officer
17,615
34.45
US$1,419,131 		17,615 34.45 US$1,419,131
2026-09-17 2026-09-15 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
1,000 -0.3%
27.00
US$100,000 		1,000 -0.3% 27.00 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
1,000
24.78
US$100,000 		1,000 24.78 US$100,000
2026-08-28 2026-08-26 S Sale
OWEN KATEY EINTERZ
Non-Executive Director
9,615 -10.9%
26.00
US$249,990 		9,615 -10.9% 26.00 US$249,990
2026-08-26 2026-08-26 PrS Proposed sale
KATHERINE E OWEN

Director

Non-Executive Director
9,615
26.00
US$249,990 		9,615 26.00 US$249,990
2026-08-20 2026-08-20 PrS Proposed sale
2.1
Harlan Robins

Former Officer

Officer
402,160
25.44
US$10,230,950 		402,160 25.44 US$10,230,950
2026-08-19 2026-08-19 PrS Proposed sale
2.1
Harlan Robins

Former Officer

Officer
215,632
25.49
US$5,496,460 		215,632 25.49 US$5,496,460
2026-08-20 2026-08-18 S Sale
2.3
HERSHBERG ROBERT
Non-Executive Director
15,664 -25.1%
24.41
US$382,358 		15,664 -25.1% 24.41 US$382,358
2026-08-20 2026-08-18 S Sale
2.3
HERSHBERG ROBERT
Non-Executive Director
15,000 -19.4%
24.39
US$365,850 		15,000 -19.4% 24.39 US$365,850
2026-08-19 2026-08-18 S Sale
1.9
ROBINS CHAD M

CEO and Chairman

Executive Director
204 -0.0%
25.14
US$5,129 		204 -0.0% 25.14 US$5,129
2026-08-19 2026-08-18 S Sale
1.9
ROBINS CHAD M

CEO and Chairman

Executive Director
278,472 -11.3%
24.48
US$6,816,995 		278,472 -11.3% 24.48 US$6,816,995
2026-08-18 2026-08-18 PrS Proposed sale
2.3
ROBERT M HERSHBERG

Director

Non-Executive Director
30,664
24.40
US$748,303 		30,664 24.40 US$748,303
2026-08-18 2026-08-18 PrS Proposed sale
2.1
Harlan Robins

Former Officer

Officer
261,044
24.56
US$6,411,241 		261,044 24.56 US$6,411,241
2026-08-18 2026-08-18 PrS Proposed sale
1.9
Chad Robins

Officer

Officer
278,676
24.56
US$6,844,283 		278,676 24.56 US$6,844,283
2026-08-19 2026-08-17 S Sale
1.9
ROBINS CHAD M

CEO and Chairman

Executive Director
2,525 -0.1%
25.57
US$64,564 		2,525 -0.1% 25.57 US$64,564
2026-08-19 2026-08-17 S Sale
1.9
ROBINS CHAD M

CEO and Chairman

Executive Director
318,799 -12.7%
25.08
US$7,995,479 		318,799 -12.7% 25.08 US$7,995,479
2026-08-19 2026-08-17 S Sale
3.4
NEUPERT PETER M
Non-Executive Director
69,690 -34.8%
25.16
US$1,753,400 		69,690 -34.8% 25.16 US$1,753,400
2026-08-19 2026-08-17 S Sale
3.4
NEUPERT PETER M
Non-Executive Director
40,000 -16.6%
25.10
US$1,004,000 		40,000 -16.6% 25.10 US$1,004,000
2026-08-19 2026-08-17 S Sale
3.4
NEUPERT PETER M
Non-Executive Director
15,000 -5.9%
25.23
US$378,450 		15,000 -5.9% 25.23 US$378,450
2026-08-17 2026-08-17 PrS Proposed sale
2.1
Harlan Robins

Former Officer

Officer
300,992
24.77
US$7,455,572 		300,992 24.77 US$7,455,572
2026-08-17 2026-08-17 PrS Proposed sale
1.9
Chad Robins

Officer

Officer
321,324
24.77
US$7,959,195 		321,324 24.77 US$7,959,195
2026-08-17 2026-08-17 PrS Proposed sale
3.4
PETER NEUPERT

Director

Non-Executive Director
124,690
25.15
US$3,136,046 		124,690 25.15 US$3,136,046
2026-08-12 2026-08-10 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
3,000 -0.8%
25.00
US$75,000 		3,000 -0.8% 25.00 US$75,000
2026-08-10 2026-08-10 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
3,000
24.93
US$74,790 		3,000 24.93 US$74,790
2026-08-03 2026-07-30 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
1,299 -0.3%
24.00
US$31,176 		1,299 -0.3% 24.00 US$31,176
2026-07-30 2026-07-30 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
1,299
22.56
US$29,305 		1,299 22.56 US$29,305
2026-07-23 2026-07-21 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
213,702 -20.8%
22.12
US$4,727,088 		213,702 -20.8% 22.12 US$4,727,088
2026-07-23 2026-07-21 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
278,698 -21.4%
21.72
US$6,053,321 		278,698 -21.4% 21.72 US$6,053,321
2026-07-21 2026-07-21 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
492,400
22.58
US$11,118,392 		492,400 22.58 US$11,118,392
2026-07-20 2026-07-16 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
5,000 -1.2%
23.00
US$115,000 		5,000 -1.2% 23.00 US$115,000
2026-07-16 2026-07-16 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
5,000
22.90
US$114,500 		5,000 22.90 US$114,500
2026-07-17 2026-07-15 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
105,762 -31.4%
22.59
US$2,389,164 		105,762 -31.4% 22.59 US$2,389,164
2026-07-07 2026-07-02 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
146,889 -12.6%
22.45
US$3,297,658 		146,889 -12.6% 22.45 US$3,297,658
2026-07-07 2026-07-02 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
239,351 -17.0%
21.74
US$5,203,491 		239,351 -17.0% 21.74 US$5,203,491
2026-07-06 2026-07-02 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
44,838 -16.3%
22.59
US$1,012,890 		44,838 -16.3% 22.59 US$1,012,890
2026-07-02 2026-07-02 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
386,240
21.19
US$8,184,426 		386,240 21.19 US$8,184,426
2026-07-06 2026-07-01 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
42,261 -15.1%
22.50
US$950,872 		42,261 -15.1% 22.50 US$950,872
2026-07-06 2026-07-01 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
8,743 -3.0%
22.18
US$193,920 		8,743 -3.0% 22.18 US$193,920
2026-07-06 2026-07-01 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
487 -0.1%
22.00
US$10,714 		487 -0.1% 22.00 US$10,714
2026-07-01 2026-07-01 PrS Proposed sale
2.6
FRANCIS LO

Officer

Officer
199,260
21.45
US$4,274,127 		199,260 21.45 US$4,274,127
2026-07-01 2026-07-01 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
487
21.45
US$10,446 		487 21.45 US$10,446
2026-06-30 2026-06-29 PlS Planned sale
2.4
BENZENO SHARON

Chief Commercial Ofc Imm Med

Officer
154,768 -41.2%
21.14
US$3,271,796 		154,768 -41.2% 21.14 US$3,271,796
2026-06-29 2026-06-29 PrS Proposed sale
2.4
SHARON BENZENO

Officer

Officer
152,931
20.96
US$3,205,434 		152,931 20.96 US$3,205,434
2026-06-30 2026-06-26 PlS Planned sale
2.4
BENZENO SHARON

Chief Commercial Ofc Imm Med

Officer
11,034 -3.9%
21.00
US$231,714 		11,034 -3.9% 21.00 US$231,714
2026-06-26 2026-06-26 PrS Proposed sale
2.4
SHARON BENZENO

Officer

Officer
12,871
20.25
US$260,638 		12,871 20.25 US$260,638
2026-06-29 2026-06-25 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
5,000 -1.2%
20.50
US$102,500 		5,000 -1.2% 20.50 US$102,500
2026-06-29 2026-06-25 PlS Planned sale
1.4
GRIFFIN MICHELLE RENEE
Non-Executive Director
52,084 -76.9%
20.18
US$1,051,055 		52,084 -76.9% 20.18 US$1,051,055
2026-06-25 2026-06-25 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
5,000
19.34
US$96,700 		5,000 19.34 US$96,700
2026-06-25 2026-06-25 PrS Proposed sale
1.4
MICHELLE GRIFFIN

Director

Non-Executive Director
52,084
19.34
US$1,007,305 		52,084 19.34 US$1,007,305
2026-06-17 2026-06-16 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
6,160 -0.4%
18.01
US$110,942 		6,160 -0.4% 18.01 US$110,942
2026-06-16 2026-06-16 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
6,160
17.22
US$106,075 		6,160 17.22 US$106,075
2026-06-17 2026-06-15 PlS Planned sale
2.1
ROBINS HARLAN S

Chief Scientific Officer

Officer
100,000 -6.6%
17.37
US$1,737,000 		100,000 -6.6% 17.37 US$1,737,000
2026-06-15 2026-06-15 PrS Proposed sale
2.1
Harlan Robins

Officer

Officer
100,000
17.46
US$1,746,000 		100,000 17.46 US$1,746,000
2026-06-15 2026-06-11 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
5,000 -1.2%
19.00
US$95,000 		5,000 -1.2% 19.00 US$95,000
2026-06-11 2026-06-11 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
5,000
17.07
US$85,350 		5,000 17.07 US$85,350
2026-06-08 2026-06-04 PlS Planned sale
2.1
BOBULSKY SUSAN

Chief Commercial Officer, MRD

Officer
11,000 -2.6%
18.00
US$198,000 		11,000 -2.6% 18.00 US$198,000
2026-06-08 2026-06-04 PlS Planned sale
2.6
LO FRANCIS

Chief People Officer

Officer
39,741 -13.7%
17.49
US$695,070 		39,741 -13.7% 17.49 US$695,070
2026-06-04 2026-06-04 PrS Proposed sale
2.1
SUSAN BOBULSKY

Officer

Officer
11,000
15.99
US$175,890 		11,000 15.99 US$175,890
2026-06-04 2026-06-04 PrS Proposed sale
2.6
FRANCIS LO

Officer

Officer
42,085
15.99
US$672,939 		42,085 15.99 US$672,939
2026-05-20 2026-05-18 S Sale
2.8
PISKEL KYLE

Chief Financial Officer

Officer
3,115 -1.2%
13.04
US$40,620 		3,115 -1.2% 13.04 US$40,620
2026-05-15 2026-05-18 PrS Proposed sale
2.8
PISKEL KYLE

Officer

Officer
3,160
12.83
US$40,543 		3,160 12.83 US$40,543
2026-04-29 2026-04-27 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,037 -4.8%
14.23
US$270,897 		19,037 -4.8% 14.23 US$270,897
2026-04-24 2026-04-24 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.8%
14.02
US$267,221 		19,060 -4.8% 14.02 US$267,221
2026-04-24 2026-04-23 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.7%
13.74
US$261,884 		19,060 -4.7% 13.74 US$261,884
2026-04-24 2026-04-22 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.7%
14.13
US$269,318 		19,060 -4.7% 14.13 US$269,318
2026-04-21 2026-04-21 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
30,941 -7.3%
14.66
US$453,595 		30,941 -7.3% 14.66 US$453,595
2026-04-21 2026-04-20 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.6%
14.55
US$277,323 		19,060 -4.6% 14.55 US$277,323
2026-04-21 2026-04-17 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.5%
14.57
US$277,704 		19,060 -4.5% 14.57 US$277,704
2026-04-16 2026-04-16 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.5%
14.18
US$270,271 		19,060 -4.5% 14.18 US$270,271
2026-04-16 2026-04-15 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.4%
14.61
US$278,467 		19,060 -4.4% 14.61 US$278,467
2026-04-16 2026-04-14 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
19,060 -4.4%
14.56
US$277,514 		19,060 -4.4% 14.56 US$277,514
2026-04-13 2026-04-13 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
3,338 -0.8%
14.08
US$46,999 		3,338 -0.8% 14.08 US$46,999
2026-04-13 2026-04-13 PlS Planned sale
2.6
RUBINSTEIN JULIE

President and COO

Officer
15,722 -3.6%
12.95
US$203,600 		15,722 -3.6% 12.95 US$203,600
Explore more

More insider trading research around Adaptive Biotechnologies Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America